THEMBA II T-Cell Vaccine: Vaccination With saRNA COVID-19 Vaccines
Clinical trial NCT05370040 · TERMINATED
Trial details
- NCT number
- NCT05370040
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-05
- Primary completion
- 2024-03-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.